Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_684c5a0829087f75b072bdf42877929a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9df40caa75d4596ff88f5790cff3d15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3482cb0d8700193d7e7b13a4e43d91e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b15591078193b30a3c04f68deb8e0e95 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 |
filingDate |
2008-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eb42bac816d39ebf6d678fdb11cd99d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d1cbd5c4a3e4852e804bb344579eb0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_040ff8117d5e78be06da6895d70f30bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3a05f649b93fd2c6bb8fd282e8a702c |
publicationDate |
2008-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008226624-A1 |
titleOfInvention |
Combined treatment of cancer by urokinase inhibition and a cytostatic anti-cancer agent for enhancing the anti-metastatic effect |
abstract |
The present invention relates to a combined treatment of cancer using a urokinase inhibitor and a cytotoxic or a cytostatic agent. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111494392-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017060771-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016336133-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9844540-B2 |
priorityDate |
2007-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |